Purchase Order HT940623P0157

Award Date 9/1/23
Potential Completion Date 9/30/26
Potential Value $249K
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the delivery of radiopharmaceutical supplies. The contract, valued at $358,406.52, was awarded by the Defense Health Agency (DHA) and has an ultimate completion date of October 1, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products...
This federal contract award is for the weekly supply of required radiopharmaceuticals to the Defense Health Agency. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has a firm fixed price of $25,055.00 and a completion date of September 30, 2024. It is not designated as a set-aside contract. Cardinal Health 414 has extensive experience providing radiopharmaceuticals, nuclear medicine supplies, and...
The Defense Health Agency awarded a firm fixed price delivery order contract worth up to $250,000.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract, which has no set-aside designation, will run through September 30, 2022. Cardinal Health 414 has previously held multiple indefinite delivery contracts to supply radiopharmaceuticals, radioactive isotopes, and other nuclear medicine products and services to the Department...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The contract, which has a ceiling value of $19,596.65, is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type and a performance period through September 30, 2024. Cardinal Health 414 is a leading provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to various...
This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc., to provide radiopharmaceuticals and related supplies to the Defense Health Agency, a component of the Department of Defense. The contract has a ceiling value of $53,310.11 and is a Blanket Purchase Agreement (BPA) call with firm-fixed pricing. The contract does not have a set-aside designation. Cardinal Health 414 has a history of delivering radiopharmaceuticals,...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceuticals, including radioactive isotopes, diagnostic imaging agents, nuclear medicine supplies, and specialty pharmaceuticals. The potential value of the contract is $145,418.67, with a completion date of September 30, 2021. Cardinal Health 414 has an established track record of delivering these...
This federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the delivery of radiopharmaceuticals to various federal healthcare agencies, including the Department of Veterans Affairs (VA), Department of Defense (DoD), and National Institutes of Health (NIH). The contract, valued at $382,756.63, is a firm fixed-price delivery order under an Indefinite Delivery Vehicle (IDV) with the VA. Cardinal Health 414 specializes in providing radiopharmaceuticals,...
This federal contract award was issued by the Defense Health Agency to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $242,673.56 firm fixed price delivery order is for the provision of radiopharmaceuticals. Cardinal Health 414 has provided similar products and services to the Department of Veterans Affairs, Department of Defense, National Institutes of Health, and other federal healthcare agencies through indefinite delivery contracts. These contracts supply radioactive...
This federal contract award is a Blanket Purchase Agreement (BPA) call placed by the Defense Health Agency with Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the delivery of radiopharmaceuticals needed for the agency's weekly studies. The contract has a firm fixed price type and a potential value of $62,287.84. The period of performance runs through September 30, 2024. Cardinal Health 414 has a history of providing a...
The U.S. Defense Health Agency awarded a $2,021,757.22 firm fixed-price purchase order contract to Cardinal Health 414, LLC for the supply of radiopharmaceuticals to support the Department of Radiology at Fort Bragg, North Carolina over a 5-year period from October 2021 through September 2026. This contract was not set aside for any specific business type. The requested radiopharmaceuticals include critical medical isotopes and radioactive products used in nuclear medicine, oncology, and...

This federal contract award is for the supply of radiopharmaceuticals to the Defense Health Agency (DHA). The $249,466.62 firm fixed-price purchase order was awarded to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract has an ultimate completion date of September 30, 2026. Cardinal Health 414 is a well-established provider of critical medical isotopes and radiopharmaceutical products used in nuclear medicine, oncology, and diagnostic imaging services, with numerous federal contract awards from agencies like the Department of Veterans Affairs (VA) and National Institutes of Health (NIH). This purchase order is not a set-aside contract. The award is part of Cardinal Health 414's portfolio of Indefinite Delivery Vehicle (IDV) contracts, including a $39.8 million multiple-award IDV with the VA's Veterans Integrated Service Network 8 for nationwide radiopharmaceutical supply. The company's expertise in handling and distributing time-sensitive, radioactive medical products is crucial for supporting the DHA's mission to provide comprehensive healthcare services.

Generated 2/12/25, 9:34 AM